Log in

Relevant bibliographies by topics / COPD, smoking, motivation, quitting

Contents

Journal articles
Books
Conference papers

Academic literature on the topic 'COPD, smoking, motivation, quitting'

Author: Grafiati

Published: 24 April 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'COPD, smoking, motivation, quitting.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "COPD, smoking, motivation, quitting"

1

Sakharova, G. M., N. S. Antonov, Yu V. Mikhaylova, and M. Yu Peredel’skaya. "Guideline on medical care for patients with chronic obstructive pulmonary disease and other lung obstructive diseases during tobacco smoking withdrawal." Russian Pulmonology 29, no. 3 (2019): 327–33. http://dx.doi.org/10.18093/0869-0189-2019-29-3-327-333.

Full text

Abstract:

Morbidity of chronic obstructive pulmonary disease (COPD) is consistently increasing last decades in Russian Federation. Similarly, the total morbidity is also increasing together with annual healthcare costs. The main risk factor of COPD is tobacco smoking. Therefore, the encouragement of smokers to quit smoking and medical care for nicotine withdrawal should be considered as main factors to control COPD morbidity. Bronchial hyperreactivity could occur early in smokers and COPD could develop in smokers with longer smoking history. Mild to moderate COPD is diagnosed in > 20% of smokers seeking medical aid for nicotine withdrawal. Typically, bronchial hyperreactivity becomes worse after quitting the smoking. This should be considered by a physician and long-acting bronchodilators should be used during nicotine withdrawal. Therefore, an individual plan is necessary for every smoking patient with COPD including quitting the smoking with consideration the severity of nicotine dependence and motivation to quit smoking. The individual plan should also include initiation or optimisation of bronchodilator therapy to prevent worsening of bronchial hyperreactivity. Quitting the smoking is the most effective intervention to slow COPD progression.

APA, Harvard, Vancouver, ISO, and other styles

2

Cavusoglu, F., A. Beser, and O. Kılınc. "The obstacles encountered by COPD patients about quitting smoking." Progress in Health Sciences 1 (June 11, 2019): 28–35. http://dx.doi.org/10.5604/01.3001.0013.3692.

Full text

Abstract:

<b>Purpose:</b> To determine the obstacles encountered by chronic obstructive respiratory disease (COPD) patients when quitting smoking. <br/><b>Materials and methods:</b> Phenomenological research design was used in this study. A total of 20 smoker COPD patients chosen with purposive sampling constituted the universe of this study. Data were collected through the in-depth interview method using semi-structured interview forms. Analysis of the data was performed with inductive analysis using the content analysis method. <br/><b>Results:</b> The challenges encountered by COPD patients when quitting smoking consist of 3 main themes and sub-themes including “İndividual specific challenges, environmental and social challenges and addiction/life with cigarettes”. <br/><b>Conclusions:</b> This study revealed the individual, environmental-social and physical, psychological and social challenges in relation to addiction encountered by COPD patients when quitting smoking. Patients should be informed about the relationship between COPD and smoking through trainings, behaviours of individuals about smoking cessation should be determined and accordingly necessary actions should be taken in line with the motivational interview principles and families be included in these actions.

APA, Harvard, Vancouver, ISO, and other styles

3

Politis, Alexios, Vasileios Ioannidis, Konstantinos I. Gourgoulianis, Zoe Daniil, and Chrissi Hatzoglou. "Effects of varenicline therapy in combination with advanced behavioral support on smoking cessation and quality of life in inpatients with acute exacerbation of COPD, bronchial asthma, or community-acquired pneumonia: A prospective, open-label, preference-based, 52-week, follow-up trial." Chronic Respiratory Disease 15, no. 2 (2017): 146–56. http://dx.doi.org/10.1177/1479972317740128.

Full text

Abstract:

Quitting smoking is the most important element in the therapeutic management of chronic respiratory diseases. Combining pharmacotherapy with behavioral support increases smoking cessation success rates. In addition, hospitalized smokers have increased motivation to quit. We investigated the efficacy on smoking cessation, of varenicline in combination with behavioral support, in smokers hospitalized due to (a) acute exacerbation of chronic obstructive pulmonary disease (COPD), or (b) bronchial asthma attack, or (c) community-acquired pneumonia (CAP). The method used is prospective, open-label, preference-based, parallel group, 52-week trial. Patients chose the smoking cessation intervention they preferred: a standard regimen of varenicline combined with post-discharge advanced behavioral support (group A) or one private consultation session during hospitalization (group B). Follow-up phone calls were scheduled in weeks 1, 2, and 4 and months 3, 6, and 9. The final hospital visit was performed in week 52. Primary outcome was success rate defined as the percentage (%) of smoking abstinence at week 52 and secondary outcomes were (a) changes in quality of life (QoL) indicated by the scores on the Short Form 36 (SF36) questionnaire and (b) predictors of smoking abstinence investigated with multiple binary logistic regression. One hundred one patients were enrolled, 44 (43.6%) in group A and 57 (56.4%) in group B. Respective abstinence rates were 54.5% and 15.8% at week 12 and 52.3% and 14.0% at week 52. Scores on SF36 were statistically significantly increased in both groups. Predictors of smoking abstinence were varenicline (odds ratio (OR) 7.29; 95% confidence interval (CI) 2.15, 24.77; p = 0.001), age (OR 1.07; 95%CI 1.00, 1.15; p = 0.042), Fagerstrom score (OR 0.37; 95%CI 0.20, 0.68; p = 0.001), SF36 domains “vitality” (OR 1.12; 95%CI 1.04, 1.21; p = 0.003), and “social functioning” (OR 0.95; 95%CI 0.90, 1.00; p = 0.041). Varenicline in combination with behavioral support resulted in high abstinence rates inpatients hospitalized for exacerbation of COPD, asthma attack, or CAP, and improved QoL.

APA, Harvard, Vancouver, ISO, and other styles

4

Butt, Kristi, and Nardine Nakhla. "Creating Standardized Tools for the Pharmacist-Led Assessment and Pharmacologic Management of Adult Canadians Wishing to Quit Smoking: A Consensus-Based Approach." Pharmacy 9, no. 2 (2021): 80. http://dx.doi.org/10.3390/pharmacy9020080.

Full text

Abstract:

Tobacco use continues to be recognized as the single most preventable cause of death worldwide. As the gatekeepers of and experts on pharmacotherapy, pharmacists play a vital role in facilitating smoking cessation. While existing frameworks have enabled pharmacists to provide smoking cessation services in Canada for many years, the way in which they are delivered vary considerably across the nation. The purpose of this initiative was to create standardized tools for the pharmacists providing cessation services to ensure all Canadians wishing to stop smoking have equal access to consistent, evidence-based care. An iterative process using repeated rounds of voting was employed to establish consensus among key opinion leaders on the most important items to include in tools for the pharmacist-led assessment and pharmacologic management of Canadian adults wishing to stop smoking. The results were used to create eight standardized documents for national use by pharmacists: a readiness to quit assessment tool, a patient consent form, a patient assessment form for past users of tobacco and/or tobacco-like products, a patient assessment form for current users of tobacco and/or tobacco-like products, a treatment algorithm, a treatment plan summary form, a prescribing documentation form, and a follow-up & monitoring documentation form. Although not described in detail in these documents, other strategies for smoking cessation (e.g., non-pharmacologic strategies (including quitting “cold turkey” and behavioural interventions), harm reduction strategies, etc.) should be considered when pharmacotherapy is inappropriate or undesired; care should be individualized based on a patient’s previous experiences and current motivation. No single approach to treatment is endorsed by the authors. The consensus-based approach described here provides a suggested framework for harmonizing the pharmacist-led management of other ailments to optimize patient care.

APA, Harvard, Vancouver, ISO, and other styles

5

Nagawa, Catherine S., Jamie M. Faro, Anitha J. Menon, et al. "Written Advice Given by African American Smokers to Their Peers: Qualitative Study of Motivational Messages." JMIR Formative Research 5, no. 4 (2021): e21481. http://dx.doi.org/10.2196/21481.

Full text

Abstract:

Background Although African Americans have the lowest rates of smoking onset and progression to daily smoking, they are less likely to achieve long-term cessation. Interventions tailored to promote use of cessation resources in African American individuals who smoke are needed. In our past work, we demonstrated the effectiveness of a technology-assisted peer-written message intervention for increasing smoking cessation in non-Hispanic White smokers. In this formative study, we have adapted this intervention to be specific for African American smokers. Objective We aimed to report on the qualitative analysis of messages written by African American current and former smokers for their peers in response to hypothetical scenarios of smokers facing cessation challenges. Methods We recruited African American adult current and former smokers (n=41) via ResearchMatch between April 2017 and November 2017. We asked participants to write motivational messages for their peers in response to smoking-related hypothetical scenarios. We also collected data on sociodemographic factors and smoking characteristics. Thematic analysis was conducted to identify cessation strategies suggested by the study participants. Results Among the study participants, 60% (25/41) were female. Additionally, more than half (23/41, 56%) were thinking about quitting, 29% (12/41) had set a quit date, and 27% (11/41) had used electronic cigarettes in the past 30 days. Themes derived from the qualitative analysis of peer-written messages were (1) behavioral strategies, (2) seeking help, (3) improvements in quality of life, (4) attitudes and expectations, and (5) mindfulness/religious or spiritual practices. Under the behavioral strategies theme, distraction strategies were the most frequently suggested strategies (referenced 84 times in the 318 messages), followed by use of evidence-based treatments/cessation strategies. Within the seeking help theme, subthemes included seeking help or support from family/friends or close social networks (referenced 56 times) and health care professionals (referenced 22 times). The most frequent subthemes that emerged from improvements in the quality of life theme included improving one’s health (referenced 22 times) and quality of life (referenced 21 times). Subthemes that emerged from the attitude and expectations theme included practicing positive self-talk (referenced 27 times), autonomy/independence from the smoking habit (referenced six times), and financial cost of smoking (referenced five times). The two subthemes that emerged from the mindfulness/religious or spiritual practices theme were use of self-awareness techniques (referenced 36 times) and religious or spiritual practices to cope (referenced 13 times). Conclusions Our approach to adapt a prior peer-message intervention to African American smokers yielded a set of evidence-based messages that may be suitable for smokers at all phases of motivation to quit (ready to quit or not ready to quit). In future research, we plan to assess the impact of texting these messages to African American smokers in a smoking cessation trial.

APA, Harvard, Vancouver, ISO, and other styles

6

Cochrane, Deborah. "Smoking in COPD: from costs to quitting." Inpharma Weekly &NA;, no. 1261 (2000): 5–6. http://dx.doi.org/10.2165/00128413-200012610-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Klemperer, Elias M., Robin Mermelstein, Timothy B. Baker, et al. "Predictors of Smoking Cessation Attempts and Success Following Motivation-Phase Interventions Among People Initially Unwilling to Quit Smoking." Nicotine & Tobacco Research 22, no. 9 (2020): 1446–52. http://dx.doi.org/10.1093/ntr/ntaa051.

Full text

Abstract:

Abstract Introduction Most people who smoke cigarettes are not willing (ie, not ready) to make a quit attempt (QA) at any given time. Unfortunately, interventions intended to increase QAs and the success of QAs are only modestly effective. Identifying processes leading to QAs and quitting success could guide intervention development. Aims and Methods This is a secondary analysis of a randomized factorial trial of 6 weeks of motivation-phase interventions among primary care patients (N = 517) who were initially unwilling to quit but were willing to reduce their smoking. Using logistic regression, we controlled for treatment condition and tested whether baseline or change in smoking-related constructs after 6 weeks of treatment predicted (1) making an at least 24 h QA between weeks 6 and 26 and (2) quitting success at week 26 (7-day point-prevalence abstinence among those who made a QA). Predictors included cigarettes/day, time to first cigarette, motivation to quit, quitting self-efficacy, anticipated urges to smoke if quit, positive affect, negative affect, and time spent around others who smoke. Results In multivariable models that included all smoking-related constructs, changes in the following variables predicted initiating a QA above and beyond other variables: greater baseline time to first cigarette (odds ratio [OR] = 1.60), increases in time to first cigarette (OR = 1.27), and increases in quitting self-efficacy (OR = 1.14). Increased motivation to quit predicted conversion of a QA into quitting success at 26 weeks (OR = 1.36). Conclusion Predictors of making a QA differed from predictors of quitting success. Predictors of QAs and success could each serve as important treatment targets of motivation-phase interventions. Implications Motivation-phase interventions for people initially unwilling to quit smoking cigarettes may be improved by striving to increase their (1) time to first cigarette and quitting self-efficacy to promote QAs and (2) motivation to quit to promote quit success. Future experimental tests of such interventions are needed to identify causal determinants of QAs and quitting success.

APA, Harvard, Vancouver, ISO, and other styles

8

Park, Hye Yun, and Don Sin. "Smoking kills, quitting heals: the importance of smoking cessation in COPD." Clinical Respiratory Journal 5, no. 4 (2011): 185–86. http://dx.doi.org/10.1111/j.1752-699x.2011.00270.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kaminsky, David A., and Theodore W. Marcy. "COPD and Smoking Cessation Motivation." Chest 125, no. 5 (2004): 1958. http://dx.doi.org/10.1378/chest.125.5.1958.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Górecka, Dorota. "COPD and Smoking Cessation Motivation." Chest 125, no. 5 (2004): 1958–59. http://dx.doi.org/10.1016/s0012-3692(15)32201-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "COPD, smoking, motivation, quitting"

1

Riley, Gillian. Lazy Persons Guide to Quitting Smoking (Lazy Person's Guides). Newleaf, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "COPD, smoking, motivation, quitting"

1

Udrescu, Lucretia, Mihai Udrescu, and Stefan Mihaicuta. "Weighted smoking score: Measuring the benefits of quitting smoking in COPD." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.oa3500.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Bjarnason, NH, KL Mikkelsen, and P. Tonnesen. "A Scale for Motivation To Quit Smoking in COPD." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a1482.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Kovačević, Tomi, Bojan Zarić, Darijo Bokan, et al. "Smoking cessation among COPD and asthma patients: burden vs. motivation." In ERS International Congress 2018 abstracts. European Respiratory Society, 2018. http://dx.doi.org/10.1183/13993003.congress-2018.pa1232.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Fernandez, D., A. Ramirez-Venegas, R. Hernandez-Zenteno, M. Mendez, J. Regalado, and R. Sansores. "Motivation and Greatest Number of Attempts Are Better Predictors To Quit Smoking Than the Presence of COPD." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2610.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!